Skip to main content
The BMJ logoLink to The BMJ
. 1995 Jul 22;311(6999):261.

Assessing coronary risk

Authors’ reply

Steven A Grover, Ilka Lowensteyn, Katja Estrey, Lawrence Joseph, Michal Abrahamowicz, Yvonne Steinert
PMCID: PMC2550332

Full text

PDF

Page 261

261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  2. Grover S. A., Abrahamowicz M., Joseph L., Brewer C., Coupal L., Suissa S. The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA. 1992 Feb 12;267(6):816–822. [PubMed] [Google Scholar]
  3. Grover S. A., Gray-Donald K., Joseph L., Abrahamowicz M., Coupal L. Life expectancy following dietary modification or smoking cessation. Estimating the benefits of a prudent lifestyle. Arch Intern Med. 1994 Aug 8;154(15):1697–1704. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES